CancerFree Biotech won the top honor, the KOZAROCKS AWARD, at the KOZAROCKS 2024 event in Okinawa, recognizing their personalized tumor cell analysis technology. Turing Drive, another Taiwanese team, received the GxPartners AWARD for their innovative autonomous driving solutions. The event, which fosters startup collaboration and innovation, highlighted the growing influence of Taiwanese startups on the international stage.

CancerFree Biotech, a Taiwanese startup, was selected to participate in OIST's prestigious startup accelerator program in Okinawa, Japan. The company's innovative "Avatar Medicine" technology, which simulates tumor responses to various drugs, has gained international recognition for its potential to improve cancer treatment. With access to OIST’s world-class research facilities and mentorship, CancerFree Biotech aims to accelerate its technology’s entry into the Japanese market and further explore personalized cancer treatment.

CancerFree Biotech won two prestigious awards at the Asian Entrepreneurship Award (AEA) in Japan, marking the fourth time the company has received an international award in 2025. The company’s "Avatar Medicine," which helps cancer patients with drug testing using tumor organoids, gained significant international recognition. This year’s event, held in Kashiwa-no-ha, Chiba, was the first in-person AEA in five years and highlighted the growing importance of innovation ecosystems in Asia.